Show an ad over header. AMP

I am the FIRST!!!

Israeli intel agencies believe Vienna talks will lead to U.S. return to Iran nuclear deal

Israeli military intelligence and senior officials in the Mossad briefed a meeting of the nation's security cabinet that talks in Vienna between Iran and other world powers will lead to the U.S. returning to the 2015 nuclear deal, two officials who attended the meeting told me.

Why it matters: The Israeli government is very concerned about a U.S. return to the nuclear deal and is trying to convince the Biden administration not to take the pressure off the Iranian regime.


Driving the news: The Mossad mainly briefed the cabinet meeting on the status of the Iranian nuclear program. Military intelligence officials discussed Iranian actions in the region at the meeting.

  • The two intelligence agencies gave similar assessments on where the Vienna talks stand.

What they are saying: “We are not very optimistic to say the least," a senior Israeli official who attended the meeting told me. "We will not be surprised if within weeks the U.S. and other world powers sign a deal with Iran.”

  • National Security Advisor Jake Sullivan told "Fox News Sunday" that the Vienna talks with Iran were "constructive" and that there is a real effort to get back to mutual compliance of the 2015 nuclear deal.
  • Sullivan added that the U.S. won’t lift sanctions unless it has "clarity and confidence" that Iran will fully return to compliance of all its obligations under the 2015 agreement.

What’s next: Israeli officials told me there were no new policy decisions made during today’s cabinet meeting, and Israel will continue the dialogue with the Biden administration on the negotiations with Iran.

  • In the coming two weeks the Israeli national security adviser Meir Ben Shabbatt, IDF chief of staff Aviv Kochavi, head of Israeli military intelligence Tamir Hayman and Mossad director Yossi Cohen will visit Washington for talks with their counterparts on Iran, officials tell me.

regular 4 post ff

infinite scroll 4 pff

The world is watching the FDA's AstraZeneca decision

AstraZeneca's coronavirus vaccine took yet another public relations hit yesterday, when the European Medicines Agency announced that the shot is linked to blood clots, and they should be listed as a "very rare" side effect of the vaccine.

What we're watching: Even before the link was announced, the U.S. didn't need the AstraZeneca vaccine, based on its existing supply of other shots. But what the Food and Drug Administration decides to do about the vaccine — if the company seeks U.S. authorization — will likely have global ramifications.

Keep reading... Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
]> &lol4;